s-nitroso-n-acetylpenicillamine has been researched along with Adenocarcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berhane, K; Boggaram, V; Salinas, D; Sparkman, L | 1 |
Amadori, D; Bolla, M; Brigliadori, G; Fabbri, F; Rosetti, M; Tesei, A; Ulivi, P; Vannini, I; Zoli, W | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Adenocarcinoma
Article | Year |
---|---|
Nitric oxide inhibits surfactant protein B gene expression in lung epithelial cells.
Topics: Adenocarcinoma; Animals; Base Sequence; Cell Line; Cells, Cultured; Dexamethasone; DNA Primers; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Lung; Lung Neoplasms; Mice; Nitric Oxide; Nitric Oxide Donors; Polymerase Chain Reaction; Pulmonary Surfactant-Associated Protein B; Respiratory Mucosa; RNA, Messenger; S-Nitroso-N-Acetylpenicillamine; Tumor Cells, Cultured | 2003 |
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
Topics: Adenocarcinoma; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Aspirin; Caspase 9; Cell Cycle; Cell Line, Tumor; Cytotoxins; Drug Resistance, Neoplasm; Flow Cytometry; Humans; Nitric Oxide Donors; Nitro Compounds; Pancreatic Neoplasms; S-Nitroso-N-Acetylpenicillamine; Salicylates | 2006 |